Increased prolactin levels during reserpine treatment of hypertensive patients
- 24 May 1976
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 235 (21) , 2316-2317
- https://doi.org/10.1001/jama.235.21.2316
Abstract
Serum prolactin levels are significantly greater among hypertensive patients receiving reserpine as compared to levels six weeks after discontinuing the treatment (P<.005). This association between regular, longterm reserpine use and greater prolactin levels may be clinically significant, since an increased incidence of breast cancer has been reported among hypertensive patients receiving reserpine. (JAMA235:2316-2317, 1976)This publication has 0 references indexed in Scilit: